[Obstetrical management of Streptococcus agalactiae]
- PMID: 12451360
[Obstetrical management of Streptococcus agalactiae]
Abstract
S. agalactiae is the main cause of maternal and neonatal infections. Correct bacteriological explorations of pregnant women and neonates with risk factors may allow early and effective antibiotherapy. The screening of S. agalactiae vaginal carriage at 34-38 weeks of amenorrhea and the administration of penicillin at delivery is considered as the best strategy for preventing S. agalactiae infections for asymptomatic patients.
Similar articles
-
[Antibiotic treatment of women with group B Steptococci during delivery?].Tidsskr Nor Laegeforen. 2008 Nov 6;128(21):2467-9. Tidsskr Nor Laegeforen. 2008. PMID: 19096471 Norwegian.
-
Group B streptococcus (GBS) colonisation among expectant Irish mothers.Ir Med J. 1998 Jan-Feb;91(1):21-2. Ir Med J. 1998. PMID: 9563251 Clinical Trial.
-
Prevention of early-onset group B streptococcal disease in infants.Tenn Med. 2005 May;98(5):232-3. Tenn Med. 2005. PMID: 15934534 No abstract available.
-
Impact of intrapartum chemoprophylaxis on neonatal sepsis.Pediatr Infect Dis J. 2003 Dec;22(12):1087-8. doi: 10.1097/01.inf.0000104181.42070.9f. Pediatr Infect Dis J. 2003. PMID: 14688571 Review. No abstract available.
-
[Streptococcus agalactiae].Pediatr Med Chir. 2003 May-Jun;25(3):207-15. Pediatr Med Chir. 2003. PMID: 14601242 Review. Italian. No abstract available.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical